Trial Profile
A study comparing endothelial permeability between non-diabetic, prediabetic and diabetic patients using gadofosveset-enhanced cardiovascular magnetic resonance imaging assessment in patients with symptoms suggestive of coronary artery disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2017
Price :
$35
*
At a glance
- Drugs Gadofosveset (Primary)
- Indications Cardiovascular disorders
- Focus Diagnostic use
- 29 Sep 2017 New trial record
- 30 Aug 2017 Results presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology